CAES
CAESCIK 0002087965
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CAES commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
CAES, a Cantor-affiliated SPAC, files S-1/A for $250M IPO at $10.00 per share
5 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative costs | 64,915 | — | 92,056 | — |
| Administrative expenses related party | 4,667 | — | 4,667 | — |
| Loss from operations | (69,582) | — | (96,723) | — |
| Interest income on investments held in the Trust Account | 204,017 | — | 204,017 | — |
| Net income | 134,435 | — | 107,294 | — |
| Basic and Diluted weighted average number of ordinary shares outstanding: | ||||
| Class A Public shares | 3,571,429 | — | 1,795,580 | — |
| Class A Private placement | 85,714 | — | 43,094 | — |
| Class B Ordinary shares(1) | 6,250,000 | 6,250,000 | 6,250,000 | 6,250,000 |
| Basic and Diluted net income per share: | ||||
| Class A Public shares | 0.01 | — | 0.01 | — |
| Class A Private placement | 0.01 | — | 0.01 | — |
| Class B Ordinary shares | 0.01 | — | 0.01 | — |
Condensed Balance Sheets
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Assets: | ||
| Current Assets: | ||
| Cash | 362,725 | — |
| Total Current Assets | 362,725 | — |
| Available-for-sale debt securities held in Trust Account, at fair value (amortized cost $250,203,338 as of June 30, 2026) | 250,228,757 | — |
| Deferred offering costs | — | 50,059 |
| Other assets | 679 | — |
| Total Assets | 250,592,161 | 50,059 |
| Liabilities and Shareholders’ Deficit: | ||
| Current Liabilities: | ||
| Accrued expenses | 51,271 | 28,478 |
| Note payable related party | — | 84,705 |
| Total Liabilities | 51,271 | 113,183 |
| Commitments and Contingencies | ||
| Class A ordinary shares subject to possible redemption, 25,000,000 and 0 shares issued and outstanding at redemption value of $10.16 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | 253,979,436 | — |
| Shareholders’ Equity: | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of both June 30, 2026 and December 31, 2025 | — | — |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 600,000 shares issued and outstanding (excluding 25,000,000 shares subject to possible redemption) as of June 30, 2026 and none issued or outstanding as of December 31, 2025 | 60 | — |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,250,000 and 7,187,500 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 625 | 719 |
| Additional paid-in capital | — | 24,281 |
| Accumulated deficit | (3,464,650) | (88,124) |
| Accumulated other comprehensive income | 25,419 | — |
| Total Shareholders’ Deficit | (3,438,546) | (63,124) |
| Total Liabilities, Commitments and Contingencies and Shareholders’ Deficit | 250,592,161 | 50,059 |
Condensed Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | 107,294 | — |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| General and administrative expenses paid by related party | 4,667 | — |
| Interest income on investments held in the Trust Account | (204,017) | — |
| Changes in operating assets and liabilities: | ||
| Deferred offering costs | 50,059 | — |
| Other assets | (679) | — |
| Accrued expenses | 22,793 | — |
| Net cash used in operating activities | (19,883) | — |
| Cash flows from investing activities: | ||
| Purchase of available-for-sale debt securities held in Trust Account | (249,999,321) | — |
| Net cash used in investing activities | (249,999,321) | — |
| Cash flows from financing activities: | ||
| Proceeds received from initial public offering | 250,000,000 | — |
| Proceeds received from private placement | 6,000,000 | — |
| Offering costs paid | (5,312,159) | — |
| Deferred offering costs paid by related party | (216,540) | — |
| Proceeds from Note payable related party | 90,182 | — |
| Payment on Note payable related party | (174,887) | — |
| Payment on Payable to related party | (4,667) | — |
| Net cash provided by financing activities | 250,381,929 | — |
| Net change in Cash | 362,725 | — |
| Cash beginning of the period | — | — |
| Cash end of the period | 362,725 | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗